Cantitate/Preț
Produs
Total produse
Vezi coșul
Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment de Richard P. Baum

Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment: Recent Results in Cancer Research, cartea 194

Editat de Richard P. Baum, Frank Rösch
en Limba Engleză Paperback – 20 sep 2014
This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics – the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified accordingly. The focus of this book is on the rapidly developing research into and clinical applications of gallium-68 and other generator-produced PET radionuclides in the personalized diagnosis and treatment of neuroendocrine tumors and other diseases. In addition, new PET radiopharmaceuticals are considered, and the latest ideas and concepts, presented. Theranostics embodies both molecular and personalized medicine. It is at the cutting edge of medicine, and the contents of this volume will be of interest to chemists, physicians, and investigators dealing with generators, PET radiochemistry, molecular imaging, and radionuclide therapy.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 111465 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 20 sep 2014 111465 lei  6-8 săpt.
Hardback (1) 135932 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 23 aug 2012 135932 lei  6-8 săpt.

Din seria Recent Results in Cancer Research

  • 5% Cancer Clinical Trials: A Critical Appraisal
    Preț: 30177 lei
  • 14% Regulatory and Economic Aspects in Oncology
    Preț: 72674 lei
  • 5% Tumor Liquid Biopsies
    Preț: 19169 lei
  • 5% Viruses and Human Cancer: From Basic Science to Clinical Prevention
    Preț: 74323 lei
  • 5% Ethical Challenges in Cancer Diagnosis and Therapy
    Preț: 86791 lei
  • 5% Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma: Liver Fluke Related Cholangiocarcinoma
    Preț: 87312 lei
  • 5% Current Problems in the Epidemiology of Cancer and Lymphomas: Symposium of the Gesellschaft zur Bekämpfung der Krebskrankheiten, Nordrhein-Westfalen, e. V
    Preț: 38032 lei
  • 15% Die tierische Zelle in Zellkultur
    Preț: 46590 lei
  • 5% Radioactive Phosphorus in the Diagnosis of Gastrointestinal Cancer
    Preț: 66856 lei
  • 5% Therapeutic Strategies in Primary and Metastatic Liver Cancer
    Preț: 68490 lei
  • 5% Locoregional High-Frequency Hyperthermia and Temperature Measurement
    Preț: 67381 lei
  • 5% Epidemiology of Malignant Melanoma
    Preț: 67553 lei
  • 5% Preoperative (Neoadjuvant) Chemotherapy
    Preț: 67499 lei
  • 5% Hyperthermia and the Therapy of Malignant Tumors
    Preț: 67760 lei
  • 5% Breast Cancer: Present Perspective of Early Diagnosis
    Preț: 34378 lei
  • 5% Minimal Neoplasia: Diagnosis and Therapy
    Preț: 67690 lei
  • 5% Application of Hyperthermia in the Treatment of Cancer
    Preț: 35263 lei
  • 5% Supportive Care in Cancer Patients
    Preț: 68579 lei
  • 5% Preclinical Hyperthermia
    Preț: 68093 lei
  • 5% Treatment of Skin Cancer
    Preț: 33858 lei
  • 5% Combined Modality Therapy of Gastrointestinal Tract Cancer
    Preț: 68368 lei
  • 5% AIDS-Related Neoplasias
    Preț: 34171 lei
  • 5% Endocrine Therapy and Growth Regulation of Breast Cancer
    Preț: 67101 lei
  • 5% Cancer Mapping
    Preț: 68177 lei
  • 5% Adjuvant Therapy of Primary Breast Cancer
    Preț: 68315 lei
  • 5% Bisphosphonates and Tumor Osteolysis
    Preț: 66998 lei
  • 5% New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease: First International Symposium on Hodgkin's Lymphoma in Cologne, October 2-3, 1987
    Preț: 68230 lei
  • 5% Hormone-Related Malignant Tumors
    Preț: 68126 lei
  • 5% Advances in Breast Cancer Detection
    Preț: 67553 lei
  • 5% Hereditary Factors in Carcinoma
    Preț: 67656 lei
  • 5% Occupational Cancer Epidemiology
    Preț: 67533 lei
  • 5% Supportive Care in Cancer Patients II
    Preț: 36009 lei
  • 5% Pathobiology of Human Germ Cell Neoplasia
    Preț: 103495 lei
  • 5% Peptides in Oncology I: LH-RH Agonists and Antagonists
    Preț: 34309 lei
  • 5% Medullary Thyroid Carcinoma
    Preț: 67656 lei
  • 5% Malignancies of the Genitourinary Tract
    Preț: 67970 lei
  • 5% Adjuvant Therapy of Breast Cancer IV
    Preț: 68093 lei
  • 5% Skin Carcinogenesis in Man and in Experimental Models
    Preț: 68456 lei
  • 5% Peptides in Oncology II: Somatostatin Analogues and Bombesin Antagonists
    Preț: 67239 lei
  • 5% Tumours in Children
    Preț: 69531 lei
  • 5% Acute and Long-Term Side-Effects of Radiotherapy: Biological Basis and Clinical Relevance
    Preț: 68004 lei
  • 5% Recent Advances in Cell Biology of Acute Leukemia: Impact on Clinical Diagnosis and Therapy
    Preț: 68682 lei
  • 5% Infectious Complications in Bone Marrow Transplantation
    Preț: 35072 lei
  • 5% Current Status of Diagnostic Cytology
    Preț: 67381 lei
  • 5% Carcinoma of the Oral Cavity and Oropharynx
    Preț: 67690 lei
  • 5% Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors
    Preț: 67587 lei
  • 5% Familial and Hereditary Tumors
    Preț: 68333 lei
  • 5% Hypercalcemia of Malignancy
    Preț: 67362 lei
  • 5% Soft Tissue Sarcomas in Adults
    Preț: 67449 lei
  • 5% Skin Cancer: Basic Science, Clinical Research and Treatment
    Preț: 68838 lei

Preț: 111465 lei

Preț vechi: 117331 lei
-5% Nou

Puncte Express: 1672
Preț estimativ în valută:
21335€ • 22942$ • 17782£

Carte tipărită la comandă

Livrare economică 20 decembrie 24 - 03 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642441608
ISBN-10: 3642441602
Pagini: 596
Ilustrații: XVIII, 578 p.
Dimensiuni: 155 x 235 x 31 mm
Greutate: 0.82 kg
Ediția:2013
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Recent Results in Cancer Research

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Cuprins

From the contents: Ge-68/Ga-68 generators.- Automation strategies in Ga-68 radiopharmaceutical preparations.- Post-processing via cation exchange cartridges.- Gallium-68 generator integrated system: elution – purification - concentration integration.- Purification and labelling strategies for 68Ga from 68Ge/68Ga generator eluate.- 67Ga and 68Ga purification studies.- The diversity of [68Ga]Ga-based imaging agents.- Nanoparticles and phage display selected peptides for imaging and therapy of cancer.- “Click” cyclized gallium-68 labeled peptides for molecular imaging and therapy: Synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.- Early experience with 68Ga-DOTATATE preparation .- 68Ga-radiopharmaceuticals for PET imaging of infection and inflammation.- 68Ga-labeled bombesin analogs for receptor mediated imaging.- A novel 68Ga-labelled pteroic acid-based PET tracer for tumour imaging via the folate receptor.- Measurement of protein synthesis: In vitro comparison of 68Ga-DOTA-puromycin, [3H]tyrosine and 2-fluoro-[3H]tyrosine.- Hypoxia imaging agents labeled with positron emitters.- Lu-177/Y-90 intermediate affinity monoclonal antibodies targeting EGFR and HER2/c-neu: preparation and preclinical evaluation.- Divergent role of 68Ga labeled somatostatin analogs in the work-up of patients with NETs.- Differential uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumours.

Recenzii

From the reviews:
“The general themes of this book (theranostics and peptide receptor–targeted radiotherapy) derive from evolving successes in the use of generator-produced 68Ga for molecular imaging of disease. … This book is an excellent resource for investigators interested in gaining a detailed understanding of the state of the art in 68Ga and peptide receptor radionuclide therapy–based theranostics for preclinical and emerging clinical applications.” (Michael K. Schultz, The Journal of Nuclear Medicine, Vol. 54 (4), April, 2013)

Textul de pe ultima copertă

This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics – the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified accordingly. The focus of this book is on the rapidly developing research into and clinical applications of gallium-68 and other generator-produced PET radionuclides in the personalized diagnosis and treatment of neuroendocrine tumors and other diseases.  In addition, new PET radiopharmaceuticals are considered, and the latest ideas and concepts, presented. Theranostics embodies both molecular and personalized medicine. It is at the cutting edge of medicine, and the contents of this volume will be of interest to chemists, physicians, and investigators dealing with generators, PET radiochemistry, molecular imaging, and radionuclide therapy.

Caracteristici

Examines in detail the latest developments in theranostics for neuroendocrine tumors and other diseases Covers a wide spectrum of topics, from radiochemistry to clinical applications Focuses on gallium-68 but also considers other PET radionuclides Includes supplementary material: sn.pub/extras